Justices reject holding generic pharmaceutical manufacturers liable for decisions of pharmacists about prescribing their products

Among the three opinions arriving on Thursday from the April argument session was Hikma Pharmaceuticals USA v. Amarin Pharma.

SCOTUS Raises Bar for ‘Skinny Label’ Drug Suits: Delaware Brief

The Supreme Court unanimously concluded a district court judge was right to dismiss Amarin’s infringement suit over claims its competitor encouraged doctors to prescribe its generic heart health drug ...
PharmExec

U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report

The 9-0 decision, authored by Justice Ketanji Brown Jackson, overturned a previous lower appellate court ruling that had ...

Conservative justices get on board with Ketanji Brown Jackson in unanimous Supreme Court decision

In a decision that crossed the ideological divide of the nation’s highest court, all six conservative justices joined Justice ...
Fierce Pharma

It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin

With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic ...